Connors Investor Services’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-30,756
Closed -$1.82M 160
2026
Q1
$1.82M Buy
30,756
+297
+1% +$19.3K 0.17% 94
2025
Q4
$1.88M Sell
30,459
-801
-3% -$49K 0.16% 89
2025
Q3
$1.95M Sell
31,260
-1,217
-4% -$84.7K 0.17% 85
2025
Q2
$2.59M Sell
32,477
-158
-0.5% -$13.2K 0.23% 78
2025
Q1
$2.81M Sell
32,635
-180
-0.5% -$14.8K 0.28% 64
2024
Q4
$2.56M Sell
32,815
-737
-2% -$57.2K 0.24% 77
2024
Q3
$2.42M Sell
33,552
-1,099
-3% -$77.8K 0.23% 82
2024
Q2
$2.39M Sell
34,651
-1,378
-4% -$93.4K 0.25% 74
2024
Q1
$2.61M Sell
36,029
-2,384
-6% -$159K 0.28% 75
2023
Q4
$2.35M Buy
38,413
+10,983
+40% +$652K 0.26% 74
2023
Q3
$1.57M Buy
+27,430
New +$1.66M 0.19% 89

Other funds holding PBH

Connors Investor Services's PBH Position: Q2 2026 in Review

Connors Investor Services sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 30,756 shares — an estimated $1.82M sold.

Connors Investor Services first reported a position in PBH in Q3 2023 and held it in 11 quarters. The position peaked at $2.81M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Connors Investor Services reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Connors Investor Services sold 30,756 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.82M.
  • Connors Investor Services first reported a position in Prestige Consumer Healthcare in Q3 2023 and held it in 11 quarters.
  • Connors Investor Services's Prestige Consumer Healthcare position peaked at $2.81M in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Connors Investor Services's 13F filing for Q2 2026, filed 14 Aug 2026.